{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:47:47Z","timestamp":1791290867068,"version":"4.3.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3288,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1038\/sj.jid.5700545","type":"journal-article","created":{"date-parts":[[2006,8,31]],"date-time":"2006-08-31T14:36:03Z","timestamp":1157034963000},"page":"2658-2663","source":"Crossref","is-referenced-by-count":86,"title":["Enhanced Survival Associated with Vitiligo Expression during Maintenance Biotherapy for Metastatic Melanoma"],"prefix":"10.1016","volume":"126","author":[{"given":"Peter D.","family":"Boasberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave S.B.","family":"Hoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence D.","family":"Piro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhide","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"Kristedja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Bhachu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina R.","family":"Deck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"O'Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.jid.5700545_bb0010","first-page":"522","article-title":"Vitiligo-like lesions in patients with melanoma treated with immunotherapy","volume":"7","author":"Buendia-Eisman","year":"1997","journal-title":"Eur J Dermatol"},{"key":"10.1038\/sj.jid.5700545_bb0015","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archderm.1987.01660320095019","article-title":"Prognostic significance of hypopigmentation in malignant melanoma","volume":"123","author":"Bystryn","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5700545_bb0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1471-4906(00)01844-5","article-title":"A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo","volume":"22","author":"Das","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1038\/sj.jid.5700545_bb0025","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"10.1038\/sj.jid.5700545_bb0030","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/sj.cgt.7700224","article-title":"DSB induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-\u03b3 retroviral vector in melanoma patients","volume":"7","author":"Fujii","year":"2000","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/sj.jid.5700545_bb0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon","volume":"354","author":"Gogas","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.jid.5700545_bb0040","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1523-1747.1998.00354.x","article-title":"Antibody responses to melanoma\/melanocyte autoantigens in melanoma patients","volume":"111","author":"Huang","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1038\/sj.jid.5700545_bb0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/08916930108994127","article-title":"Autoimmune aspects of vitiligo","volume":"34","author":"Kemp","year":"2001","journal-title":"Autoimmunity"},{"key":"10.1038\/sj.jid.5700545_bb0050","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1046\/j.0022-202x.2001.01605.x","article-title":"Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo","volume":"117","author":"Le Gal","year":"2001","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/sj.jid.5700545_bb0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1087-0024.2004.00825.x","article-title":"Autoimmune aspects of depigmentation in vitiligo","volume":"9","author":"Le Poole","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/sj.jid.5700545_bb0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Norlund","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.jid.5700545_bb0065","first-page":"2775","article-title":"Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy","volume":"8","author":"O'Day","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1038\/sj.jid.5700545_bb0070","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1200\/JCO.1999.17.9.2752","article-title":"Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2 granulocyte colony-stimulating factor, and Tamoxifen for patients with metastatic melanoma","volume":"17","author":"O'Day","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1038\/sj.jid.5700545_bb0075","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1038\/sj.jid.5700545_bb0080","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 (TRP-2) immune responses in vitiligo patients and melanoma patients responding to active specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1038\/sj.jid.5700545_bb0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo","volume":"16","author":"Ongenae","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1038\/sj.jid.5700545_bb0090","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1200\/JCO.2001.19.15.3477","article-title":"Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma","volume":"19","author":"Phan","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1038\/sj.jid.5700545_bb0095","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1073\/pnas.1533209100","article-title":"Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma","volume":"100","author":"Phan","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.jid.5700545_bb0100","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.1992.10.8.1338","article-title":"Sequential chemoimmunotherapy in the treatment of metastatic melanoma","volume":"10","author":"Richards","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1038\/sj.jid.5700545_bb0105","first-page":"155","article-title":"Prognostic significance of cutaneous depigmentation in Mexican patients with malignant melanoma","volume":"29","author":"Rodriguez-Cuevas","year":"1998","journal-title":"Arch Med Res"},{"key":"10.1038\/sj.jid.5700545_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002371-199601000-00009","article-title":"Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy","volume":"19","author":"Rosenberg","year":"1996","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"10.1038\/sj.jid.5700545_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000247693","article-title":"Vitiligo and cutaneous melanoma","volume":"183","author":"Schallreuter","year":"1991","journal-title":"Dermatologica"},{"key":"10.1038\/sj.jid.5700545_bb0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/mthe.2002.0537","article-title":"Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma","volume":"5","author":"Tanaka","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/sj.jid.5700545_bb0125","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1200\/JCO.2004.12.009","article-title":"Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients","volume":"22","author":"Takeuchi","year":"2004","journal-title":"J Clin Oncol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15327068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15327068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T00:45:13Z","timestamp":1555807513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15327068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0022202X15327068"],"URL":"https:\/\/doi.org\/10.1038\/sj.jid.5700545","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}